You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

02 October 2017

Breakthrough as single-dose HIV treatment deal announced

Agreement ushers in first single-dose, affordable HIV treatment for low- and middle-income countries.

0
21 August 2017

Better patient communication gets more people admitting adherence issues

A pilot that saw health workers adopt ‘patient-centred’ communication at an HIV clinic in rural Tanzania led to a three-fold increase in the number of people openly reporting treatment adherence problems.

0
28 June 2017

HIV wonder drug dolutegravir to be rolled-out in Kenya

UNITAID partners to bring newer and more effective HIV treatment options to countries where they are needed most.

0
03 March 2017

Decentralised antiretroviral treatment delivery in an urban setting – a Kinshasa success

The first ever study evaluating the decentralising of HIV care through antiretroviral treatment (ART) distribution centres shows low rates of patient loss in the city.

0
14 February 2017

HIV self-testing a useful tool for pre-exposure prophylaxis (PrEP) delivery in Kenya

Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.

0
10 February 2017

Lack of female head of household and distance to clinic linked to loss to follow-up in Malawi

Identifying individuals at high risk of disengaging with HIV care remains an important strategy for realising the benefits of antiretroviral treatment for public health.

0
19 January 2017

Rural and urban patterns of HIV drug resistance in South Africa

HIV is more proactively monitored among urban HIV patients than rural patients, and drug resistance and treatment failure is less prevalent. However outcomes for second line treatment remain similar.

0
11 January 2017

Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach

Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.

0
10 September 2015

Workplace HIV treatment programmes have significant benefits

Company-provided antiretroviral treatment (ART) programmes are found to be highly cost-effective in settings with a high HIV prevalence.

0